HMGCR and cancer: Similarly weak evidence was demonstrated for a protective effect of HMGCR inhibition on cancer risk (OR equivalent to 1 mmol/L lowering of LDL cholesterol 0.86, 95% CI 0.73–1.02, p = 0.09) [58], with comparable odds when analyses were restricted to status of oestrogen receptor.